Literature DB >> 29333608

The synergistic effect of PDT and oxacillin on clinical isolates of Staphylococcus aureus.

Natanel Iluz1,2, Yasmin Maor3, Natan Keller2,4, Zvi Malik1,5.   

Abstract

BACKGROUND: Staphylococcus aureus is a major pathogen in clinical microbiology. It is known to cause infections at various body sites and can be life-threatening. The development of resistance to many well-established antibiotic treatments and the prevalence of methicillin-resistant S. aureus (MRAS) among hospital patients and the general community pose challenges in treating the pathogen. The antimicrobial effect of photodynamic therapy (PDT) has been a subject of study for a long time and can offer new strategies for dealing with resistant strains.
OBJECTIVE: In our study, we searched for a positive synergistic relationship between PDT and the standard antibiotics used to treat S. aureus and MRSA infections.
MATERIALS AND METHODS: The phototoxic profile of deuteroporphyrin (DP) in both resistant and susceptible clinical strains of S. aureus was determined by plating of treated and untreated broth cultures. Electron microscopy imaging was done to explore possible sites of damage and free-radical accumulation in the cells during DP-PDT. Minimal inhibitory concentration (MIC) of oxacillin, gentamicin, vancomycin, rifampin, and fusidic acid was determined using the broth dilution method, and the checkerboard method was used to detect and evaluate the synergistic potential of DP-PDT and antibiotic combinations. A synergistic combination was further characterized using broth cultures and plating.
RESULTS: DP-PDT using a light dose of 15 J/cm2 showed a bactericidal effect even with a small concentration of 17 μM DP. Transmission electron microscopy indicated profound damage in the cell wall and cell membrane, and the appearance of mesosome-like structures. Free radicals tend to localize in the cell membrane and inside the mesosome. No synergistic effect was detected by combining PDT with gentamicin, vancomycin, rifampin, and fusidic acid treatments. A positive synergistic effect was observed only in DP-PDT-oxacillin combined treatment using the checkerboard method. The effect was observed in clinical antibiotic-resistant isolates after DP-PDT using a light dose of 46 J/cm2 and small concentrations of DP. Oxacillin MIC decreased below 2 μg/ml in resistant strains under such conditions. Cultures which did not undergo new cycles of DP-PDT recovered their original oxacillin resistance after a few generations.
CONCLUSIONS: PDT with porphyrins shows possible new therapeutic options in treating drug-resistant S. aureus at body sites suitable for irradiation. The synergistic effect of DP-PDT with oxacillin on clinical strains illustrates the potential of PDT to augment traditional antibiotic treatment based on cell wall inhibitors. Lasers Surg. Med. 50:535-551, 2018.
© 2018 Wiley Periodicals, Inc. © 2018 Wiley Periodicals, Inc.

Entities:  

Keywords:  MDR; MRSA; Staphylococcus aureus; VISA; deuteroporphyrin; oxacillin; photodynamic therapy; synergism

Mesh:

Substances:

Year:  2018        PMID: 29333608     DOI: 10.1002/lsm.22785

Source DB:  PubMed          Journal:  Lasers Surg Med        ISSN: 0196-8092            Impact factor:   4.025


  10 in total

1.  Nonconventional Therapeutics against Staphylococcus aureus.

Authors:  Caroline M Grunenwald; Monique R Bennett; Eric P Skaar
Journal:  Microbiol Spectr       Date:  2018-11

Review 2.  Phototherapy and optical waveguides for the treatment of infection.

Authors:  Dingbowen Wang; Michelle Laurel Kuzma; Xinyu Tan; Tong-Chuan He; Cheng Dong; Zhiwen Liu; Jian Yang
Journal:  Adv Drug Deliv Rev       Date:  2021-11-03       Impact factor: 15.470

3.  Anti-listeria Activities of Linalool and Its Mechanism Revealed by Comparative Transcriptome Analysis.

Authors:  Zhipeng Gao; Joy D Van Nostrand; Jizhong Zhou; Weiming Zhong; Kangyong Chen; Jiajing Guo
Journal:  Front Microbiol       Date:  2019-12-20       Impact factor: 5.640

Review 4.  Design of Photosensitizing Agents for Targeted Antimicrobial Photodynamic Therapy.

Authors:  Maxime Klausen; Muhammed Ucuncu; Mark Bradley
Journal:  Molecules       Date:  2020-11-10       Impact factor: 4.411

5.  In Vitro and In Vivo Bactericidal and Antibiofilm Efficacy of Alpha Mangostin Against Staphylococcus aureus Persister Cells.

Authors:  LewisOscar Felix; Biswajit Mishra; Rajamohammed Khader; Narchonai Ganesan; Eleftherios Mylonakis
Journal:  Front Cell Infect Microbiol       Date:  2022-07-22       Impact factor: 6.073

Review 6.  Combined Antimicrobial Activity of Photodynamic Inactivation and Antimicrobials-State of the Art.

Authors:  Agata Wozniak; Mariusz Grinholc
Journal:  Front Microbiol       Date:  2018-05-08       Impact factor: 5.640

7.  The Latest Time Point of Retreatment (LTPR) as a Novel Method to Determine Antibacterial Effects for Binary Use of Cold Atmospheric Plasma and Conventional Agents.

Authors:  Sandra Schramm; Karl-Anton Hiller; Sylvia Cantzler; Hannes Weilemann; Maximilian Cantzler; Julia L Zimmermann; Fabian Cieplik; Tim Maisch
Journal:  Front Microbiol       Date:  2020-10-29       Impact factor: 5.640

8.  Propolis nanoparticle enhances the potency of antimicrobial photodynamic therapy against Streptococcus mutans in a synergistic manner.

Authors:  Shima Afrasiabi; Maryam Pourhajibagher; Nasim Chiniforush; Abbas Bahador
Journal:  Sci Rep       Date:  2020-09-23       Impact factor: 4.379

9.  Poly Lactic-co-Glycolic Acid-Coated Toluidine Blue Nanoparticles for the Antibacterial Therapy of Wounds.

Authors:  Xiaomu Xu; Bo Liu; Haiyan Wu; Yichi Zhang; Xinyuan Tian; Jijing Tian; Tianlong Liu
Journal:  Nanomaterials (Basel)       Date:  2021-12-14       Impact factor: 5.076

Review 10.  Photodynamic Therapy Combined with Antibiotics or Antifungals against Microorganisms That Cause Skin and Soft Tissue Infections: A Planktonic and Biofilm Approach to Overcome Resistances.

Authors:  Vanesa Pérez-Laguna; Isabel García-Luque; Sofía Ballesta; Antonio Rezusta; Yolanda Gilaberte
Journal:  Pharmaceuticals (Basel)       Date:  2021-06-23
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.